These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15154843

  • 1. Modified-vaccinia-virus-Ankara (MVA) priming and fowlpox-virus booster elicit a stronger CD8+ T-cell response in mice against an HIV-1 epitope than does a DNA/poxvirus prime-booster approach.
    Vázquez-Blomquist D, Quintana D, Duarte CA.
    Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):313-8. PubMed ID: 15154843
    [Abstract] [Full Text] [Related]

  • 2. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE, Abaitua F, Rodríguez D, Esteban M.
    Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077
    [Abstract] [Full Text] [Related]

  • 3. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.
    Virus Res; 2006 Mar 15; 116(1-2):11-20. PubMed ID: 16214252
    [Abstract] [Full Text] [Related]

  • 4. A vaccination strategy consisting of Semliki-Forest-virus (SFV) DNA prime and fowlpox-virus boost significantly protects mice from a recombinant (HIV-1) vaccinia-virus infection.
    Quintana-Vázquez D, Vázquez-Blomquist DM, Galbán Rodríguez E, Herrera Buch AM, Duarte Cano CA.
    Biotechnol Appl Biochem; 2005 Feb 15; 41(Pt 1):59-66. PubMed ID: 15099194
    [Abstract] [Full Text] [Related]

  • 5. Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide.
    Vázquez Blomquist D, Green P, Laidlaw SM, Skinner MA, Borrow P, Duarte CA.
    Viral Immunol; 2002 Feb 15; 15(2):337-56. PubMed ID: 12081016
    [Abstract] [Full Text] [Related]

  • 6. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K.
    Clin Immunol; 2006 Apr 15; 119(1):32-7. PubMed ID: 16458074
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.
    Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, Boyle DB, Ramsay AJ, Ramshaw IA.
    Vaccine; 2006 Jul 26; 24(31-32):5881-95. PubMed ID: 16759767
    [Abstract] [Full Text] [Related]

  • 8. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
    Prieur E, Gilbert SC, Schneider J, Moore AC, Sheu EG, Goonetilleke N, Robson KJ, Hill AV.
    Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):290-5. PubMed ID: 14694197
    [Abstract] [Full Text] [Related]

  • 9. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D, Matsuo K, Pinyosukhee N, Thongdeejaroen W, Leang-Aramgul P, Sawanpanyalert P, Warachit P.
    Southeast Asian J Trop Med Public Health; 2009 Mar 06; 40(2):273-81. PubMed ID: 19323012
    [Abstract] [Full Text] [Related]

  • 10. 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
    Harrison JM, Bertram EM, Boyle DB, Coupar BE, Ranasinghe C, Ramshaw IA.
    Vaccine; 2006 Nov 17; 24(47-48):6867-74. PubMed ID: 17050052
    [Abstract] [Full Text] [Related]

  • 11. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells.
    Radaelli A, Bonduelle O, Beggio P, Mahe B, Pozzi E, Elli V, Paganini M, Zanotto C, De Giuli Morghen C, Combadière B.
    Vaccine; 2007 Mar 01; 25(11):2128-38. PubMed ID: 17241705
    [Abstract] [Full Text] [Related]

  • 12. Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
    Liu J, Hellerstein M, McDonnel M, Amara RR, Wyatt LS, Moss B, Robinson HL.
    Vaccine; 2007 Apr 12; 25(15):2951-8. PubMed ID: 17360078
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
    Bejon P, Peshu N, Gilbert SC, Lowe BS, Molyneux CS, Forsdyke J, Lang T, Hill AV, Marsh K.
    Clin Infect Dis; 2006 Apr 15; 42(8):1102-10. PubMed ID: 16575727
    [Abstract] [Full Text] [Related]

  • 15. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE, Rodríguez D, Rodríguez JR, Abaitua F, Duarte C, Esteban M.
    Vaccine; 2001 Dec 12; 20(5-6):961-71. PubMed ID: 11738764
    [Abstract] [Full Text] [Related]

  • 16. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
    Gómez CE, Nájera JL, Sánchez R, Jiménez V, Esteban M.
    Vaccine; 2009 May 21; 27(24):3165-74. PubMed ID: 19446187
    [Abstract] [Full Text] [Related]

  • 17. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X, Liu L, Ren L, Qiu C, Wan Y, Xu J.
    Vaccine; 2007 Dec 17; 25(52):8874-84. PubMed ID: 18061316
    [Abstract] [Full Text] [Related]

  • 18. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
    Hodge JW, Poole DJ, Aarts WM, Gómez Yafal A, Gritz L, Schlom J.
    Cancer Res; 2003 Nov 15; 63(22):7942-9. PubMed ID: 14633725
    [Abstract] [Full Text] [Related]

  • 19. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):158-66. PubMed ID: 19411115
    [Abstract] [Full Text] [Related]

  • 20. DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
    Hill AV, Reece W, Gothard P, Moorthy V, Roberts M, Flanagan K, Plebanski M, Hannan C, Hu JT, Anderson R, Degano P, Schneider J, Prieur E, Sheu E, Gilbert SC.
    Dev Biol (Basel); 2000 Oct 15; 104():171-9. PubMed ID: 11713817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.